Nebenwirkungen · Pregabalin Viatris Pharma (previously Pregabalin Pfizer)
Pregabalin Viatris Pharma 25 mg hard capsules Pregabalin Viatris Pharma 50 mg hard capsules Pregabalin Viatris Pharma 75 mg hard capsules Pregabalin Viatris Pharma 100 mg hard capsules Pregabalin Viatris Pharma 150 mg hard capsules Pregabalin Viatris Pharma 200 mg hard capsules Pregabalin Viatris Pharma 225 mg hard capsules Pregabalin Viatris Pharma 300 mg hard capsules · Abschnitt 4.8 · PDF-Seite 11
HOS-132673 · Präparat HOS-097274
After discontinuation of short-term and long-term treatment with pregabalin withdrawal symptoms have been observed. The following symptoms have been reported: insomnia, headache, nausea, anxiety, diarrhoea, flu syndrome, convulsions, nervousness, depression, suicidal ideation, pain, hyperhidrosis and dizziness. These symptoms may indicate drug dependence. The patient should be informed about this at the start of the treatment. Concerning discontinuation of long-term treatment of pregabalin, data suggest that the incidence and severity of withdrawal symptoms may be dose-related (see sections 4.2 and 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-24T15:36:00Z · SHA-256 82ee888afd9191364ca2885cfe33f3a6014857efdff1de95ea2361849731a42c · Passage 64fe5e016f8aee7c06df7813d06a99bf9be54c620cf8da3008c7b1744678437f · Zeichen 7383–7994 im Abschnitt